|
June 09
Syngenta licenses
Chromatin gene stacking technology for sugar cane
December 08
Chromatin
raises $12.4 million in Series C financing
October 07
Syngenta
licenses Chromatin gene stacking technology
May 07
Chromatin and
Monsanto announce agreement to advance gene stacking technology
January 07
U.S. patent
gives Chromatin Inc. exclusive mini-chromosome rights in plants
- Issued patent covers methods for using mini-chromosomes to
produce transgenic plants
March 05
Chromatin Inc. among first
Illinois companies to benefit from state's new $50 million technology
development fund
February 05
Chromatin launches
joint corn development program at University of Illinois
January 05
Chromatin Inc. hires
Joseph Feldman as Vice President of Business Development
October 04
Chromatin raises US$7.3 million in Series B financing -
Funds will further the development of mini-chromosome
technology for improved commercial crops
Nature Methods
publishes breakthrough by Chromatin co-founder for locating centromeres
May 04
Chromatin hires Michael Pauly
as Chief Scientific Officer
March 04
Anthony J. Cavalieri,
former Pioneer Hi-Bred VP
of Trait and
Technology Development,
joins Board of Directors of Chromatin Inc.
Start-up's work could
produce biotech crops with identical traits
February 04
Chicago firm
developing method of reliably making genetically modified seeds
January 04
Chromatin announces
international partnerships to introduce mini-chromosomes into canola
September 03
Chromatin Inc.
secures $2.7 million in ATP/NIH grants to develop mini-chromosome
technology;
technology overcomes barrier to the introduction of
multiple genes into plants, enables improved crops for pharmaceutical,
agricultural, industrial products
January 03
Chromatin Inc.
appoints Dr. Mich Hein as President and CEO
|
